SUMMARY
AI Generated Content
- Research reveals semaglutide (Wegovy) costs just $3/month to produce.
- Current US prices reach $200/month, driven by market strategies, not costs.
- Affordable access could aid obesity/diabetes treatment globally, benefiting millions.
AD




